FP7H2020
Institut klinické a experimentální mediciny
- Country
- CZCzechia
- Defence projects
- 0
- Projects, all programmes
- 11
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 2,875,302
- Active
- 2008 to 2021
Projects
11 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| STOPSTORMA PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE-ENTRANT TACHYCARDIA | H2020 | 2021 | Participant | EUR 165,375 |
| TTV GUIDE TXPERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL | H2020 | 2021 | Participant | EUR 288,750 |
| BEAT AFGround-BrEAking Electroporation-based inTervention for Atrial Fibrillation treatment (BEAT AF) | H2020 | 2021 | Participant | EUR 214,063 |
| BETATRAINEuropean Training Network for Excellence in Molecular Imaging in Diabetes | FP7 | 2012 | Participant | EUR 213,980 |
| PRIORITYProteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria | FP7 | 2012 | Participant | EUR 64,940 |
| EUROSTAMA Europe-wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches | FP7 | 2012 | Participant | EUR 213,200 |
| BIO-DrIMPersonalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation | FP7 | 2012 | Participant | EUR 500,000 |
| MABSOTDevelopment of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation | FP7 | 2010 | Participant | EUR 353,271 |
| RENAL FUNCTIONS/EETSRole of Epoxyeicosatrienoic Acids in the Regulation of Blood Pressure, Renal Hemodynamics and Sodium Excretion in Renovascular Model of Hypertension | FP7 | 2009 | Coordinator | EUR 75,000 |
| DIAdvisorPersonal Glucose Predictive Diabetes Advisor | FP7 | 2008 | Participant | EUR 292,755 |
| ENCITEEuropean Network for Cell Imaging and Tracking Expertise | FP7 | 2008 | Participant | EUR 493,968 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.